Jasper Therapeutics (JSPR) Tops Q2 EPS by 12c

Jasper Therapeutics (NASDAQ: JSPR) reported Q2 EPS of ($0.97), $0.12 better than the analyst estimate of ($1.09).

For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.

You May Also Be Interested In

• Freedom Broker Starts Holley (HLLY) at Buy
• Planet Fitness operator United PF Holdings in debt-for-equity talks with lenders - Bloomberg
• U.S. military says it is striking Iran over Strait of Hormuz attacks